EL7.AI
StocksMedium•12 November 2026•
1 min read

Windward Bio Prices Nasdaq IPO at $17.00 Per Share

Windward Bio Prices Nasdaq IPO at $17.00 Per Share

Key Facts

1Windward Bio priced its IPO of 10,294,117 common shares at $17.00 per share.
2The company expects gross proceeds of $225.0 million from the IPO and concurrent private placement.

Windward Bio priced its initial public offering of 10,294,117 common shares at $17.00 per share on the Nasdaq. GlobeNewswire reported that the company expects gross proceeds of $225.0 million from the IPO and a concurrent private placement, before deducting underwriting discounts and expenses.

The company is transitioning to a public entity to fund the development of ultra-long-acting antibody medicines for serious respiratory and dermatologic diseases. This pricing follows US economic data on November 12, 2026, which showed initial jobless claims at 200,000 and a four-week average of 195,250 claims.

Trading of the shares is expected to begin on the Nasdaq Global Select Market under the ticker WWB on November 13, 2026. This debut coincides with the scheduled release of the Producer Price Index (PPI) on the same date, with a forecast of 0.4% monthly growth.